US Stock MarketDetailed Quotes

CRXM Gene Biotherapeutics

Watchlist

0.000001
0.0000000.00%

15min DelayClose Feb 9 16:00 ET

64.93Market Cap0.00P/E (TTM)

Gene Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

50.80%1.26M

168.95%477.94K

121.49%388.7K

0.76%242.66K

-37.08%152.88K

-28.05%837K

177.71K

175.49K

240.83K

242.98K

Selling and administrative expenses

75.99%1.04M

253.51%422.2K

182.85%322.58K

7.24%193.54K

-40.82%106.28K

-34.62%593.55K

--119.43K

--114.05K

--180.47K

--179.6K

Research and development costs

-10.63%217.58K

-4.35%55.74K

7.61%66.12K

-18.61%49.12K

-26.47%46.61K

-4.68%243.45K

--58.28K

--61.44K

--60.36K

--63.38K

Operating profit

-50.80%-1.26M

-168.95%-477.94K

-121.49%-388.7K

-0.76%-242.66K

37.08%-152.88K

28.05%-837K

-177.71K

-175.49K

-240.83K

-242.98K

Net non-operating interest income expense

-31.09%-57.4K

-5.27%-12.85K

-16.02%-12.71K

-51.53%-15.92K

-57.28%-15.93K

-10.81%-43.79K

-12.2K

-10.95K

-10.5K

-10.13K

Non-operating interest expense

31.09%57.4K

5.27%12.85K

16.02%12.71K

51.53%15.92K

57.28%15.93K

10.81%43.79K

--12.2K

--10.95K

--10.5K

--10.13K

Other net income (expense)

-59.76%668.03K

-99.92%1.28K

666.75K

155.37%1.66M

1.62M

35.99K

Special income (charges)

-59.76%668.03K

-99.92%1.28K

--0

--666.75K

----

155.37%1.66M

--1.62M

--35.99K

--0

----

-Less:Other special charges

95.90%-68.03K

99.92%-1.28K

----

---66.75K

----

---1.66M

---1.62M

---35.99K

----

-Gain on sale of property,plant,equipment

--600K

--0

--600K

----

--0

----

Income before tax

-183.63%-651.55K

-134.14%-489.51K

-166.79%-401.41K

262.40%408.18K

33.30%-168.81K

240.96%779.13K

1.43M

-150.46K

-251.33K

-253.11K

Income tax

Net income

-183.63%-651.55K

-134.14%-489.51K

-166.79%-401.41K

262.41%408.18K

33.30%-168.81K

240.96%779.13K

1.43M

-150.46K

-251.33K

-253.11K

Net income continuous Operations

-183.63%-651.55K

-134.14%-489.51K

-166.79%-401.41K

262.40%408.18K

33.30%-168.81K

240.96%779.13K

--1.43M

---150.46K

---251.33K

---253.11K

Minority interest income

-52.66%-133.65K

-190.95%-46.72K

-103.50%-40.27K

-10.61%-27.61K

28.75%-19.05K

25.72%-87.55K

-16.06K

-19.79K

-24.96K

-26.74K

Net income attributable to the parent company

-159.76%-517.9K

-130.54%-442.79K

-176.38%-361.13K

292.51%435.79K

33.84%-149.76K

299.29%866.68K

1.45M

-130.67K

-226.37K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-159.76%-517.9K

-130.54%-442.79K

-176.38%-361.13K

292.51%435.79K

33.84%-149.76K

299.29%866.68K

1.45M

-130.67K

-226.37K

Basic earnings per share

-140.00%-0.02

-118.89%-0.017

-50.00%-0.015

250.00%0.03

50.00%-0.01

266.67%0.05

0.09

-0.01

-0.02

Diluted earnings per share

-140.00%-0.02

-118.89%-0.017

-50.00%-0.015

121.29%0.0043

50.00%-0.01

266.67%0.05

0.09

-0.01

-0.02

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	50.80%1.26M	168.95%477.94K	121.49%388.7K	0.76%242.66K	-37.08%152.88K	-28.05%837K	177.71K	175.49K	240.83K	242.98K
Selling and administrative expenses	75.99%1.04M	253.51%422.2K	182.85%322.58K	7.24%193.54K	-40.82%106.28K	-34.62%593.55K	--119.43K	--114.05K	--180.47K	--179.6K
Research and development costs	-10.63%217.58K	-4.35%55.74K	7.61%66.12K	-18.61%49.12K	-26.47%46.61K	-4.68%243.45K	--58.28K	--61.44K	--60.36K	--63.38K
Operating profit	-50.80%-1.26M	-168.95%-477.94K	-121.49%-388.7K	-0.76%-242.66K	37.08%-152.88K	28.05%-837K	-177.71K	-175.49K	-240.83K	-242.98K
Net non-operating interest income expense	-31.09%-57.4K	-5.27%-12.85K	-16.02%-12.71K	-51.53%-15.92K	-57.28%-15.93K	-10.81%-43.79K	-12.2K	-10.95K	-10.5K	-10.13K
Non-operating interest expense	31.09%57.4K	5.27%12.85K	16.02%12.71K	51.53%15.92K	57.28%15.93K	10.81%43.79K	--12.2K	--10.95K	--10.5K	--10.13K
Other net income (expense)	-59.76%668.03K	-99.92%1.28K		666.75K		155.37%1.66M	1.62M	35.99K
Special income (charges)	-59.76%668.03K	-99.92%1.28K	--0	--666.75K	----	155.37%1.66M	--1.62M	--35.99K	--0	----
-Less:Other special charges	95.90%-68.03K	99.92%-1.28K	----	---66.75K	----	---1.66M	---1.62M	---35.99K	----	----
-Gain on sale of property,plant,equipment	--600K	--0	--0	--600K	----	--0	--0	--0	----	----
Income before tax	-183.63%-651.55K	-134.14%-489.51K	-166.79%-401.41K	262.40%408.18K	33.30%-168.81K	240.96%779.13K	1.43M	-150.46K	-251.33K	-253.11K
Income tax
Net income	-183.63%-651.55K	-134.14%-489.51K	-166.79%-401.41K	262.41%408.18K	33.30%-168.81K	240.96%779.13K	1.43M	-150.46K	-251.33K	-253.11K
Net income continuous Operations	-183.63%-651.55K	-134.14%-489.51K	-166.79%-401.41K	262.40%408.18K	33.30%-168.81K	240.96%779.13K	--1.43M	---150.46K	---251.33K	---253.11K
Minority interest income	-52.66%-133.65K	-190.95%-46.72K	-103.50%-40.27K	-10.61%-27.61K	28.75%-19.05K	25.72%-87.55K	-16.06K	-19.79K	-24.96K	-26.74K
Net income attributable to the parent company	-159.76%-517.9K	-130.54%-442.79K	-176.38%-361.13K	292.51%435.79K	33.84%-149.76K	299.29%866.68K	1.45M	-130.67K	-226.37K	-226.37K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-159.76%-517.9K	-130.54%-442.79K	-176.38%-361.13K	292.51%435.79K	33.84%-149.76K	299.29%866.68K	1.45M	-130.67K	-226.37K	-226.37K
Basic earnings per share	-140.00%-0.02	-118.89%-0.017	-50.00%-0.015	250.00%0.03	50.00%-0.01	266.67%0.05	0.09	-0.01	-0.02	-0.02
Diluted earnings per share	-140.00%-0.02	-118.89%-0.017	-50.00%-0.015	121.29%0.0043	50.00%-0.01	266.67%0.05	0.09	-0.01	-0.02	-0.02
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall